Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-139513
Filing Date
2024-12-23
Accepted
2024-12-23 15:23:29
Documents
2
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 6965
2 EX-24 aim-ex24.htm EX-24 5264
  Complete submission text file 0000950170-24-139513.txt   13743
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Issuer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O T&M PARTNERS 790 N. WATER ST. #2175 MILWAUKEE WI 53202
Business Address
KELLNER TED D (Reporting) CIK: 0001187524 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-27072 | Film No.: 241573167